APO Research
Talk to an analyst

APO RESEARCH · REPORT

Darunavir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Darunavir Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchDarunavir Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Darunavir Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Darunavir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Darunavir Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Darunavir Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Darunavir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Darunavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Darunavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Darunavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Darunavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Darunavir include Janssen Therapeutics, Teva, Mylan, Lupin, Hetero and Cipla, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Darunavir, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Darunavir, also provides the revenue of main regions and countries. Of the upcoming market potential for Darunavir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Darunavir revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Darunavir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Darunavir revenue, projected growth trends, production technology, application and end-user industry.

Darunavir Segment by Company

Janssen Therapeutics

Teva

Mylan

Lupin

Hetero

Cipla

Darunavir Segment by Type

Tablet

Oral suspension

Darunavir Segment by Application

Hospital

Drug store

Darunavir Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darunavir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Darunavir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darunavir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Darunavir in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Darunavir company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Darunavir revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Darunavir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Player Table 3. Oral suspension Major Player Table 4. Global Darunavir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Drug store Major Player Table 7. Darunavir Industry Trends Table 8. Darunavir Industry Drivers Table 9. Darunavir Industry Opportunities and Challenges Table 10. Darunavir Industry Restraints Table 11. Global Darunavir Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Darunavir Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Darunavir Market Share by Region (2021-2026) Table 14. Global Darunavir Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Darunavir Market Share by Region (2027-2032) Table 16. Global Darunavir Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Darunavir Revenue Market Share by Players (2021-2026) Table 18. Global Darunavir Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Darunavir Key Players Headquarters & Area Served Table 20. Global Darunavir Players, Product Type & Application Table 21. Global Darunavir Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Darunavir by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Darunavir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Darunavir Revenue Market Share by Type (2021-2026) Table 28. Global Darunavir Revenue Market Share by Type (2027-2032) Table 29. Global Darunavir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Darunavir Revenue Market Share by Application (2021-2026) Table 33. Global Darunavir Revenue Market Share by Application (2027-2032) Table 34. Janssen Therapeutics Company Information Table 35. Janssen Therapeutics Business Overview Table 36. Janssen Therapeutics Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Janssen Therapeutics Darunavir Product Portfolio Table 38. Janssen Therapeutics Recent Development Table 39. Teva Company Information Table 40. Teva Business Overview Table 41. Teva Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Darunavir Product Portfolio Table 43. Teva Recent Development Table 44. Mylan Company Information Table 45. Mylan Business Overview Table 46. Mylan Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Mylan Darunavir Product Portfolio Table 48. Mylan Recent Development Table 49. Lupin Company Information Table 50. Lupin Business Overview Table 51. Lupin Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Lupin Darunavir Product Portfolio Table 53. Lupin Recent Development Table 54. Hetero Company Information Table 55. Hetero Business Overview Table 56. Hetero Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Hetero Darunavir Product Portfolio Table 58. Hetero Recent Development Table 59. Cipla Company Information Table 60. Cipla Business Overview Table 61. Cipla Darunavir Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Cipla Darunavir Product Portfolio Table 63. Cipla Recent Development Table 64. North America Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 67. North America Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 68. North America Darunavir Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Darunavir Revenue by Country (2021-2026) & (US$ Million) Table 70. North America Darunavir Revenue by Country (US$ Million) & (2027-2032) Table 71. Europe Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 72. Europe Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 73. Europe Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 74. Europe Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 75. Europe Darunavir Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Darunavir Revenue by Country (2021-2026) & (US$ Million) Table 77. Europe Darunavir Revenue by Country (US$ Million) & (2027-2032) Table 78. China Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 79. China Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 80. China Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 81. China Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 82. Asia Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 83. Asia Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 84. Asia Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 85. Asia Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 86. Asia Darunavir Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Darunavir Revenue by Region (US$ Million) & (2021-2026) Table 88. Asia Darunavir Revenue by Region (US$ Million) & (2027-2032) Table 89. SAMEA Darunavir Revenue by Type (2021-2026) & (US$ Million) Table 90. SAMEA Darunavir Revenue by Type (2027-2032) & (US$ Million) Table 91. SAMEA Darunavir Revenue by Application (2021-2026) & (US$ Million) Table 92. SAMEA Darunavir Revenue by Application (2027-2032) & (US$ Million) Table 93. SAMEA Darunavir Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. SAMEA Darunavir Revenue by Country (2021-2026) & (US$ Million) Table 95. SAMEA Darunavir Revenue by Country (US$ Million) & (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Darunavir Image Figure 2. Global Darunavir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Darunavir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Oral suspension Image Figure 6. Global Darunavir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Darunavir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Darunavir Market Size (US$ Million) & (2021-2032) Figure 11. Global Darunavir Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Darunavir Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Darunavir Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Darunavir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Darunavir Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Darunavir Revenue Market Share by Type (2021-2032) Figure 18. Global Darunavir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Darunavir Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Darunavir Revenue Market Share by Application (2021-2032) Figure 21. North America Darunavir Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Darunavir Revenue Share by Type (2021-2032) Figure 23. North America Darunavir Revenue Share by Application (2021-2032) Figure 24. North America Darunavir Revenue Share by Country (2021-2032) Figure 25. United States Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Darunavir Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Darunavir Revenue Share by Type (2021-2032) Figure 30. Europe Darunavir Revenue Share by Application (2021-2032) Figure 31. Europe Darunavir Revenue Share by Country (2021-2032) Figure 32. Germany Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Darunavir Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Darunavir Revenue Share by Type (2021-2032) Figure 42. China Darunavir Revenue Share by Application (2021-2032) Figure 43. Asia Darunavir Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Darunavir Revenue Share by Type (2021-2032) Figure 45. Asia Darunavir Revenue Share by Application (2021-2032) Figure 46. Asia Darunavir Revenue Share by Region (2021-2032) Figure 47. Japan Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Darunavir Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Darunavir Revenue Share by Type (2021-2032) Figure 55. SAMEA Darunavir Revenue Share by Application (2021-2032) Figure 56. SAMEA Darunavir Revenue Share by Country (2021-2032) Figure 57. Brazil Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Darunavir Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral suspension
Applications
  • Hospital
  • Drug store
Companies covered
  • Janssen Therapeutics
  • Teva
  • Mylan
  • Lupin
  • Hetero
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Darunavir Market by Type
  3. 1.2.1 Global Darunavir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Oral suspension
  6. 1.3 Darunavir Market by Application
  7. 1.3.1 Global Darunavir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Darunavir Market Dynamics
  1. 2.1 Darunavir Industry Trends
  2. 2.2 Darunavir Industry Drivers
  3. 2.3 Darunavir Industry Opportunities and Challenges
  4. 2.4 Darunavir Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Darunavir Market Perspective (2021-2032)
  2. 3.2 Global Darunavir Growth Trends by Region
  3. 3.2.1 Global Darunavir Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Darunavir Market Size by Region (2021-2026)
  5. 3.2.3 Global Darunavir Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Darunavir Revenue by Players
  2. 4.1.1 Global Darunavir Revenue by Players (2021-2026)
  3. 4.1.2 Global Darunavir Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Darunavir Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Darunavir Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Darunavir Key Players Headquarters & Area Served
  7. 4.4 Global Darunavir Players, Product Type & Application
  8. 4.5 Global Darunavir Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Darunavir Market CR5 and HHI
  11. 4.6.3 2025 Darunavir Tier 1, Tier 2, and Tier 3
5 Darunavir Market Size by Type
  1. 5.1 Global Darunavir Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Darunavir Revenue by Type (2021-2032)
  3. 5.3 Global Darunavir Revenue Market Share by Type (2021-2032)
6 Darunavir Market Size by Application
  1. 6.1 Global Darunavir Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Darunavir Revenue by Application (2021-2032)
  3. 6.3 Global Darunavir Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Janssen Therapeutics
  2. 7.1.1 Janssen Therapeutics Company Information
  3. 7.1.2 Janssen Therapeutics Business Overview
  4. 7.1.3 Janssen Therapeutics Darunavir Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Therapeutics Darunavir Product Portfolio
  6. 7.1.5 Janssen Therapeutics Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Darunavir Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Darunavir Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Darunavir Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Darunavir Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Lupin
  20. 7.4.1 Lupin Company Information
  21. 7.4.2 Lupin Business Overview
  22. 7.4.3 Lupin Darunavir Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lupin Darunavir Product Portfolio
  24. 7.4.5 Lupin Recent Developments
  25. 7.5 Hetero
  26. 7.5.1 Hetero Company Information
  27. 7.5.2 Hetero Business Overview
  28. 7.5.3 Hetero Darunavir Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hetero Darunavir Product Portfolio
  30. 7.5.5 Hetero Recent Developments
  31. 7.6 Cipla
  32. 7.6.1 Cipla Company Information
  33. 7.6.2 Cipla Business Overview
  34. 7.6.3 Cipla Darunavir Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cipla Darunavir Product Portfolio
  36. 7.6.5 Cipla Recent Developments
8 North America
  1. 8.1 North America Darunavir Revenue (2021-2032)
  2. 8.2 North America Darunavir Revenue by Type (2021-2032)
  3. 8.2.1 North America Darunavir Revenue by Type (2021-2026)
  4. 8.2.2 North America Darunavir Revenue by Type (2027-2032)
  5. 8.3 North America Darunavir Revenue Share by Type (2021-2032)
  6. 8.4 North America Darunavir Revenue by Application (2021-2032)
  7. 8.4.1 North America Darunavir Revenue by Application (2021-2026)
  8. 8.4.2 North America Darunavir Revenue by Application (2027-2032)
  9. 8.5 North America Darunavir Revenue Share by Application (2021-2032)
  10. 8.6 North America Darunavir Revenue by Country
  11. 8.6.1 North America Darunavir Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Darunavir Revenue by Country (2021-2026)
  13. 8.6.3 North America Darunavir Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Darunavir Revenue (2021-2032)
  2. 9.2 Europe Darunavir Revenue by Type (2021-2032)
  3. 9.2.1 Europe Darunavir Revenue by Type (2021-2026)
  4. 9.2.2 Europe Darunavir Revenue by Type (2027-2032)
  5. 9.3 Europe Darunavir Revenue Share by Type (2021-2032)
  6. 9.4 Europe Darunavir Revenue by Application (2021-2032)
  7. 9.4.1 Europe Darunavir Revenue by Application (2021-2026)
  8. 9.4.2 Europe Darunavir Revenue by Application (2027-2032)
  9. 9.5 Europe Darunavir Revenue Share by Application (2021-2032)
  10. 9.6 Europe Darunavir Revenue by Country
  11. 9.6.1 Europe Darunavir Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Darunavir Revenue by Country (2021-2026)
  13. 9.6.3 Europe Darunavir Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Darunavir Revenue (2021-2032)
  2. 10.2 China Darunavir Revenue by Type (2021-2032)
  3. 10.2.1 China Darunavir Revenue by Type (2021-2026)
  4. 10.2.2 China Darunavir Revenue by Type (2027-2032)
  5. 10.3 China Darunavir Revenue Share by Type (2021-2032)
  6. 10.4 China Darunavir Revenue by Application (2021-2032)
  7. 10.4.1 China Darunavir Revenue by Application (2021-2026)
  8. 10.4.2 China Darunavir Revenue by Application (2027-2032)
  9. 10.5 China Darunavir Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Darunavir Revenue (2021-2032)
  2. 11.2 Asia Darunavir Revenue by Type (2021-2032)
  3. 11.2.1 Asia Darunavir Revenue by Type (2021-2026)
  4. 11.2.2 Asia Darunavir Revenue by Type (2027-2032)
  5. 11.3 Asia Darunavir Revenue Share by Type (2021-2032)
  6. 11.4 Asia Darunavir Revenue by Application (2021-2032)
  7. 11.4.1 Asia Darunavir Revenue by Application (2021-2026)
  8. 11.4.2 Asia Darunavir Revenue by Application (2027-2032)
  9. 11.5 Asia Darunavir Revenue Share by Application (2021-2032)
  10. 11.6 Asia Darunavir Revenue by Country
  11. 11.6.1 Asia Darunavir Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Darunavir Revenue by Country (2021-2026)
  13. 11.6.3 Asia Darunavir Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Darunavir Revenue (2021-2032)
  2. 12.2 SAMEA Darunavir Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Darunavir Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Darunavir Revenue by Type (2027-2032)
  5. 12.3 SAMEA Darunavir Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Darunavir Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Darunavir Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Darunavir Revenue by Application (2027-2032)
  9. 12.5 SAMEA Darunavir Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Darunavir Revenue by Country
  11. 12.6.1 SAMEA Darunavir Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Darunavir Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Darunavir Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst